Recombinant Human Activated Protein C for Adults with Septic Shock. A Randomized Controlled Trial

Abstract

In adults with established and severe septic shock, DAA showed no evidence of benefit or harm. Clinical trial registered with www.clinicaltrials.gov (NCT00625209).